Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Webster

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Food Protection|November 12, 2010
Risk ranking: investigating expert and public differences in evaluating food safety hazardsKevin Webster, Cindy Jardine, Sean B Cash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Project Zero Delay: a process for accelerating the activation of cancer clinical trialsRazelle Kurzrock, Susan Pilat, Marcel Bartolazzi, et al.
Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.
Environment International|September 26, 2020
Belowground changes to community structure alter methane-cycling dynamics in AmazoniaKyle M Meyer, Andrew H Morris, Kevin Webster, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Food Protection|November 12, 2010
Risk ranking: investigating expert and public differences in evaluating food safety hazardsKevin Webster, Cindy Jardine, Sean B Cash, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Project Zero Delay: a process for accelerating the activation of cancer clinical trialsRazelle Kurzrock, Susan Pilat, Marcel Bartolazzi, et al.
Molecular Cancer Therapeutics|June 11, 2009
Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathwayKenneth Thress, Terry Macintyre, Haiyun Wang, et al.
Environment International|September 26, 2020
Belowground changes to community structure alter methane-cycling dynamics in AmazoniaKyle M Meyer, Andrew H Morris, Kevin Webster, et al.
Pageof 1